Epitalon Dosage: Research Protocols for Longevity and Sleep

The most widely documented Epitalon dosage in longevity research is 2 mg administered subcutaneously each evening for 20 consecutive days. This cycle is typically repeated three times per year. Because the peptide acts on pathways related to pineal gland function and melatonin production, administration is generally scheduled 30 to 60 minutes before sleep.

The Science of Epitalon and the Pineal Gland

Epitalon is a synthetic tetrapeptide based on epithalamin, a natural extract derived from the pineal gland. In biological models, it is evaluated for its potential to support telomerase activity—an enzyme involved in maintaining telomere length during cellular division—and for its role in regulating circadian rhythms.

Research involving elderly subjects indicates that epithalamin may support the normal function of circadian melatonin rhythms. Because of this mechanism, Epitalon is heavily studied in the context of cellular aging and sleep architecture.

Documented Epitalon Dosage Protocols

Unlike compounds intended for continuous daily use, Epitalon relies on a pulsed dosing model. Researchers and self-experimenters typically structure administration into concentrated, short-term courses followed by long periods of cessation.

The Standard 20-Day Model

The established baseline for Epitalon administration is the 20-day protocol. This model focuses on steady, moderate exposure:

• Dose: 2 mg daily (subcutaneous).
• Duration: 20 consecutive days.
• Total Volume: 40 mg total per course.
• Frequency: Repeated 3 times per year, spaced approximately 4 months apart.

Short-Duration, High-Dose Models

Some community reports reference accelerated protocols that utilize higher daily volumes over a shorter timeframe. These models typically involve:

• Dose: 5 to 10 mg daily.
• Duration: 10 consecutive days.
• Total Volume: 50 to 100 mg per course.

While a split administration (e.g., 5 mg in the morning and 5 mg in the evening) is occasionally documented in these high-dose models, evening-only administration remains the prevailing standard due to the compound's influence on sleep cycles.

Reconstitution and Measurement

Accurate measurement requires understanding the concentration of the reconstituted vial. A common configuration involves a 20 mg vial of lyophilized Epitalon.

When a 20 mg vial is reconstituted with 2 mL of bacteriostatic water, the resulting concentration is 10 mg/mL.

• A 2 mg dose requires 0.2 mL of liquid, which equals 20 units on a standard U-100 insulin syringe.
• A 1 mg dose requires 0.1 mL of liquid, which equals 10 units.

Once reconstituted, the peptide must be refrigerated at 2-8°C and is generally used within 21 days to maintain stability.

Sleep Cycle Observations and Related Compounds

Because Epitalon is involved in pineal regulation, community reports frequently note changes in sleep patterns. Increased sleepiness following evening administration is common, as are reports of highly vivid dreams, both of which are consistent with enhanced melatonin activity.

In broader longevity research, Epitalon is sometimes evaluated alongside related compounds to target multiple biological pathways simultaneously. For example, it is occasionally paired with GHK-Cu (often dosed at 1.7 mg in the morning) to study concurrent telomerase and collagen support. It is also investigated alongside mitochondrial peptides like SS-31 (for mitochondrial membrane support) or MOTS-c (for metabolic regulation).

The Bottom Line

Epitalon is primarily investigated through pulsed, periodic dosing models, with the 2 mg, 20-day evening cycle serving as the established baseline for studying its effects on circadian rhythms and cellular longevity. Because individual responses to sleep-regulating peptides can vary widely, systematically logging doses, administration times, and resulting sleep architecture over multiple cycles is what separates rigorous self-research from guesswork.